Figure 2.
Changes in the IL-6 serum level during biological treatment (A – adalimumab, B – etanercept, C – ustekinumab, D – infliximab). Data shown as means ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.